3.1 | Patient demographics
Since the onset of the pre-transplant RVI screening program at our
institution, 161 patients received allogeneic HSCT who were eligible to
be included in the study based on viral PCR testing. Patients age ranged
from 0.3 to 28.6 years, with the average being 9.7 years. 66 patients
were female and 95 patients were male. Table 1 outlines indications for
transplant, use of T cell depletion, conditioning intensity, use of
serotherapy, stem cell source, HLA mismatch, and CMV concordance.